Amicus Therapeutics (FOLD) News Today $5.96 -0.33 (-5.25%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$5.98 +0.02 (+0.40%) As of 07/18/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FOLD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Amicus gains as Morgan Stanley upgrades on Aurobindo case and Pom-Op switchingJuly 18 at 2:56 AM | msn.comAmicus Therapeutics (NASDAQ:FOLD) Shares Gap Up - Here's WhyJuly 17 at 12:33 PM | marketbeat.comAmicus Therapeutics (NASDAQ:FOLD) Upgraded at Morgan StanleyJuly 17 at 8:10 AM | marketbeat.comAmicus (FOLD) Gets Japan Approval for Pombiliti + OpfoldaJuly 16 at 7:58 PM | finance.yahoo.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Acquired by Rice Hall James & Associates LLCJuly 14, 2025 | marketbeat.comStephens Investment Management Group LLC Buys Shares of 612,470 Amicus Therapeutics, Inc. (NASDAQ:FOLD)July 14, 2025 | marketbeat.comQ2 EPS Forecast for Amicus Therapeutics Boosted by AnalystJuly 13, 2025 | americanbankingnews.comEquities Analysts Offer Predictions for FOLD Q1 EarningsJuly 12, 2025 | americanbankingnews.comBrokerages Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) PT at $16.22July 12, 2025 | americanbankingnews.comQ2 EPS Estimate for Amicus Therapeutics Boosted by AnalystJuly 11, 2025 | marketbeat.comQ1 EPS Estimate for Amicus Therapeutics Lifted by AnalystJuly 10, 2025 | marketbeat.comSHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term FOLD Investors to Contact the FirmJuly 10, 2025 | prnewswire.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Rating of "Moderate Buy" by BrokeragesJuly 9, 2025 | marketbeat.comAmicus Therapeutics’ Migalastat Study: A Potential Game-Changer for Fabry Disease TreatmentJuly 3, 2025 | tipranks.comAmicus Therapeutics Advances Pompe Disease Research with New Observational StudyJuly 3, 2025 | tipranks.comAmicus Therapeutics, Inc. (FOLD) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comAmicus Therapeutics stock hits 52-week low at $5.55June 25, 2025 | investing.comJapan approves Amicus Therapeutics' treatment for late-onset Pompe diseaseJune 25, 2025 | investing.comAmicus Therapeutics Announces Approval of Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) in JapanJune 25, 2025 | globenewswire.comAmicus Therapeutics Publishes Positive PROPEL Study Data for Pompe Disease TreatmentJune 24, 2025 | msn.comAmicus Therapeutics (NASDAQ:FOLD) Reaches New 12-Month Low - Time to Sell?June 23, 2025 | marketbeat.comU.S. Supreme Court Decision Cites NCLA's Amicus Brief in Preserving Access to Federal CourtsJune 20, 2025 | globenewswire.comSG Americas Securities LLC Acquires 58,496 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)June 20, 2025 | marketbeat.comAmicus Therapeutics (NASDAQ:FOLD) Hits New 52-Week Low - Time to Sell?June 17, 2025 | marketbeat.comThe Association of American Physicians and Surgeons files an Amicus Brief in the Supreme Court in Support of the Right to Conversion TherapyJune 16, 2025 | globenewswire.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Rating of "Moderate Buy" from AnalystsJune 14, 2025 | marketbeat.comIn NCLA Amicus Win, Supreme Court Revives Innocent Family's Suit over FBI's Wrong-House RaidJune 13, 2025 | globenewswire.comIn NCLA Amicus Win, District Court Topples Kansas Dog Kennel No-Warrant Inspection RegimeJune 12, 2025 | globenewswire.comAmicus Therapeutics: Opportunity Awaits In This Beaten Down PharmaJune 12, 2025 | seekingalpha.comWedge Capital Management L L P NC Decreases Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)June 11, 2025 | marketbeat.comZacks Research Analysts Decrease Earnings Estimates for FOLDJune 6, 2025 | marketbeat.comNew Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and NerveJune 3, 2025 | globenewswire.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 471,902 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)June 1, 2025 | marketbeat.comTwo Sigma Advisers LP Buys 52,000 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)June 1, 2025 | marketbeat.comTwo Sigma Investments LP Boosts Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)June 1, 2025 | marketbeat.comMillennium Management LLC Has $4.31 Million Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)May 31, 2025 | marketbeat.comAmicus Therapeutics to Present at Upcoming Investor Conferences in June 2025May 30, 2025 | globenewswire.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Holdings Decreased by Voloridge Investment Management LLCMay 27, 2025 | marketbeat.comWoodline Partners LP Sells 726,952 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)May 27, 2025 | marketbeat.comMan Group plc Cuts Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)May 27, 2025 | marketbeat.comNeo Ivy Capital Management Acquires 329,959 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)May 25, 2025 | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Purchased by Squarepoint Ops LLCMay 25, 2025 | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Stake Cut by Teza Capital Management LLCMay 23, 2025 | marketbeat.comNuveen Asset Management LLC Buys 159,139 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)May 23, 2025 | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Recommendation of "Moderate Buy" by AnalystsMay 22, 2025 | marketbeat.com3,350,000 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Acquired by Vestal Point Capital LPMay 21, 2025 | marketbeat.comSovereign s Capital Management LLC Makes New Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD)May 21, 2025 | marketbeat.comRafferty Asset Management LLC Sells 73,883 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)May 21, 2025 | marketbeat.comDeutsche Bank AG Grows Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)May 20, 2025 | marketbeat.comProsight Management LP Makes New Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD)May 17, 2025 | marketbeat.com Get Amicus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FOLD and its competitors with MarketBeat's FREE daily newsletter. Email Address FOLD Media Mentions By Week FOLD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FOLD News Sentiment▼0.950.57▲Average Medical News Sentiment FOLD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FOLD Articles This Week▼96▲FOLD Articles Average Week Get Amicus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FOLD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HALO News MDGL News RGEN News IONS News ALKS News LGND News BCRX News CLDX News DVAX News INVA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FOLD) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amicus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amicus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FOLD Stock Alerts